Event free survival at 12 months (EFS12) in stage 1 DLBCL - a reassuring milestone?

Leuk Lymphoma. 2020 Nov;61(11):2542-2543. doi: 10.1080/10428194.2020.1808214. Epub 2020 Aug 19.

Authors

Katharine L Lewis^{1

2

3}, Chan Yoon Cheah^{1

2

3

4}

Affiliations

¹ Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.
² Linear Clinical Research, Nedlands, Australia.
³ Medical School, University of Western Australia, Crawley, Australia.
⁴ Department of Haematology, Pathwest Laboratory Medicine, Nedlands, Australia.

PMID: 32812823
DOI: 10.1080/10428194.2020.1808214

No abstract available

Publication types

Comment

MeSH terms

Biomarkers
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Progression-Free Survival
Registries
Thailand

Substances

Biomarkers